[Skip to Content]
[Skip to Content Landing]
Article
March 1988

Following Up Patients With Central Retinal Vein Occlusion

Author Affiliations

Madison, Wis

Arch Ophthalmol. 1988;106(3):324-326. doi:10.1001/archopht.1988.01060130350018
Abstract

The correct identification of eyes with central retinal vein occlusion (CRVO) that are at high risk for developing iris neovascularization is of great importance in managing this potentially blinding disorder. Iris neovascularization can lead rapidly to neovascular glaucoma; panretinal photocoagulation of eyes with iris new vessels may cause regression of the new vessels and prevent the development of glaucoma.1-3 As with the growth of retinal or disc new vessels in the proliferative retinopathies, the growth of iris new vessels in CRVO is probably caused by a neovasculogenesis factor released by poorly perfused (ischemic) retina.4 This concept is supported by a number of fluorescein angiographic studies5-9 demonstrating that eyes with CRVO with extensive capillary nonperfusion have a relatively high rate (40% to 60% ) of developing iris new vessels, while eyes with CRVO with relatively good capillary perfusion develop iris new vessels at

See also p 348 and 353.

References
1.
Laatikainen L, Kohner EM, Khoury D, et al:  Panretinal photocoagulation in central retinal vein occlusion: A randomized controlled clinical study .  Br J Ophthalmol 1977;61:741-753.Crossref
2.
May DR, Klein ML, Peyman GA, et al:  Xenon arc panretinal photocoagulation for central vein occlusion: A randomized prospective study .  Br J Ophthalmol 1979;63:725-734.Crossref
3.
Magargal LE, Brown GC, Augsburger JJ, et al:  Efficacy of panretinal photocoagulation in preventing neovascular glaucoma following ischemic central retinal vein obstruction .  Ophthalmology 1982;89:780-783.Crossref
4.
Patz A:  Clinical and experimental studies on retinal neovascularization .  Am J Ophthalmol 1982;94:715-743.Crossref
5.
Laatikainen L, Kohner EM:  Fluorescein angiography and its prognostic significance in central retinal vein occlusion .  Br J Ophthalmol 1976;60:411-418.Crossref
6.
Magargal LE, Brown GC, Augsburger JJ, et al:  Neovascular glaucoma following central retinal vein obstruction .  Ophthalmology 1981;88:1095-1101.Crossref
7.
Magargal LE, Donoso LA, Sanborn GE:  Retinal ischemia and risk of neovascularization following central retinal vein obstruction .  Ophthalmology 1982;89:1241-1245.Crossref
8.
Hayreh SS:  Classification of central retinal vein occlusion .  Ophthalmology 1983;90:458-474.Crossref
9.
Hayreh SS, Rajas P, Podhajsky P:  Ocular neovascularization with retinal vascular occlusion: III. Incidence of ocular neovascularization with retinal vein occlusion .  Ophthalmology 1983;90:488-506.Crossref
10.
Welch JC, Augsburger JJ:  Assessment of angiographic retinal capillary nonperfusion in central retinal vein occlusion .  Am J Ophthalmol 1987;103:761-766.
11.
Johnson MA, Marcus S, Elman MJ, et al:  Neovascularization in Central Retinal Vein Occlusion: Electroretinographic Findings .  Arch Ophthalmol 1987;106:348-352.Crossref
12.
Kaye SB, Harding SP:  Early electroretinography in unilateral central retinal vein occlusion as a predictor of rubeosis iridis .  Arch Ophthalmol 1987;106:353-356.Crossref
13.
Servais GE, Thompson HS, Hayreh SS:  Relative afferent pupillary defect in central retinal vein occlusion .  Ophthalmology 1986;93:301-303.Crossref
14.
Thompson HS, Corbett JJ, Cox TA:  How to measure the relative afferent pupillary defect .  Surv Ophthalmol 1981;26:39-42.Crossref
15.
Early Treatment Diabetic Retinopathy Study: Manual of Operations, accession No. PB85 22306/AS. Springfield, Va, US Dept of Commerce, National Technical Information Service.
16.
Minturn J, Brown GC:  Progression of nonischemic central retinal vein obstruction to the ischemic variant .  Ophthalmology 1986;93:1158-1162.Crossref
×